LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes

Pingping Li, Dayoung Oh, Gautam Bandyopadhyay, William S. Lagakos, Saswata Talukdar, Olivia Osborn, Andrew Johnson, Heekyung Chung, Rafael Mayoral, Michael Maris, Jachelle M. Ofrecio, Sayaka Taguchi, Min Lu, Jerrold M. Olefsky

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Insulin resistance results from several pathophysiologic mechanisms, including chronic tissue inflammation and defective insulin signaling. We found that liver, muscle and adipose tissue exhibit higher levels of the chemotactic eicosanoid LTB4 in obese high-fat diet (HFD)-fed mice. Inhibition of the LTB4 receptor Ltb4r1, through either genetic or pharmacologic loss of function, led to an anti-inflammatory phenotype with protection from insulin resistance and hepatic steatosis. In vitro treatment with LTB4 directly enhanced macrophage chemotaxis, stimulated inflammatory pathways, reduced insulin-stimulated glucose uptake in L6 myocytes, and impaired insulin-mediated suppression of hepatic glucose output in primary mouse hepatocytes. This was accompanied by lower insulin-stimulated Akt phosphorylation and higher Irs-1/2 serine phosphorylation, and all of these events were dependent on Gαi and Jnk1, two downstream mediators of Ltb4r1 signaling. These observations elucidate a novel role of the LTB4-Ltb4r1 signaling pathway in hepatocyte and myocyte insulin resistance, and they show that in vivo inhibition of Ltb4r1 leads to robust insulin-sensitizing effects.

Original languageEnglish (US)
Pages (from-to)239-247
Number of pages9
JournalNature Medicine
Volume21
Issue number3
DOIs
StatePublished - Jan 1 2015

Fingerprint

Obese Mice
Leukotriene B4
Macrophages
Muscle Cells
Insulin Resistance
Hepatocytes
Insulin
Liver
Leukotriene B4 Receptors
Phosphorylation
Glucose
Eicosanoids
High Fat Diet
Chemotaxis
Serine
Tissue
Adipose Tissue
Anti-Inflammatory Agents
Inflammation
Phenotype

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Li, P., Oh, D., Bandyopadhyay, G., Lagakos, W. S., Talukdar, S., Osborn, O., ... Olefsky, J. M. (2015). LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nature Medicine, 21(3), 239-247. https://doi.org/10.1038/nm.3800

LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. / Li, Pingping; Oh, Dayoung; Bandyopadhyay, Gautam; Lagakos, William S.; Talukdar, Saswata; Osborn, Olivia; Johnson, Andrew; Chung, Heekyung; Mayoral, Rafael; Maris, Michael; Ofrecio, Jachelle M.; Taguchi, Sayaka; Lu, Min; Olefsky, Jerrold M.

In: Nature Medicine, Vol. 21, No. 3, 01.01.2015, p. 239-247.

Research output: Contribution to journalArticle

Li, P, Oh, D, Bandyopadhyay, G, Lagakos, WS, Talukdar, S, Osborn, O, Johnson, A, Chung, H, Mayoral, R, Maris, M, Ofrecio, JM, Taguchi, S, Lu, M & Olefsky, JM 2015, 'LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes', Nature Medicine, vol. 21, no. 3, pp. 239-247. https://doi.org/10.1038/nm.3800
Li, Pingping ; Oh, Dayoung ; Bandyopadhyay, Gautam ; Lagakos, William S. ; Talukdar, Saswata ; Osborn, Olivia ; Johnson, Andrew ; Chung, Heekyung ; Mayoral, Rafael ; Maris, Michael ; Ofrecio, Jachelle M. ; Taguchi, Sayaka ; Lu, Min ; Olefsky, Jerrold M. / LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. In: Nature Medicine. 2015 ; Vol. 21, No. 3. pp. 239-247.
@article{b0499b2050214aafb9432e0dcc259968,
title = "LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes",
abstract = "Insulin resistance results from several pathophysiologic mechanisms, including chronic tissue inflammation and defective insulin signaling. We found that liver, muscle and adipose tissue exhibit higher levels of the chemotactic eicosanoid LTB4 in obese high-fat diet (HFD)-fed mice. Inhibition of the LTB4 receptor Ltb4r1, through either genetic or pharmacologic loss of function, led to an anti-inflammatory phenotype with protection from insulin resistance and hepatic steatosis. In vitro treatment with LTB4 directly enhanced macrophage chemotaxis, stimulated inflammatory pathways, reduced insulin-stimulated glucose uptake in L6 myocytes, and impaired insulin-mediated suppression of hepatic glucose output in primary mouse hepatocytes. This was accompanied by lower insulin-stimulated Akt phosphorylation and higher Irs-1/2 serine phosphorylation, and all of these events were dependent on Gαi and Jnk1, two downstream mediators of Ltb4r1 signaling. These observations elucidate a novel role of the LTB4-Ltb4r1 signaling pathway in hepatocyte and myocyte insulin resistance, and they show that in vivo inhibition of Ltb4r1 leads to robust insulin-sensitizing effects.",
author = "Pingping Li and Dayoung Oh and Gautam Bandyopadhyay and Lagakos, {William S.} and Saswata Talukdar and Olivia Osborn and Andrew Johnson and Heekyung Chung and Rafael Mayoral and Michael Maris and Ofrecio, {Jachelle M.} and Sayaka Taguchi and Min Lu and Olefsky, {Jerrold M.}",
year = "2015",
month = "1",
day = "1",
doi = "10.1038/nm.3800",
language = "English (US)",
volume = "21",
pages = "239--247",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes

AU - Li, Pingping

AU - Oh, Dayoung

AU - Bandyopadhyay, Gautam

AU - Lagakos, William S.

AU - Talukdar, Saswata

AU - Osborn, Olivia

AU - Johnson, Andrew

AU - Chung, Heekyung

AU - Mayoral, Rafael

AU - Maris, Michael

AU - Ofrecio, Jachelle M.

AU - Taguchi, Sayaka

AU - Lu, Min

AU - Olefsky, Jerrold M.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Insulin resistance results from several pathophysiologic mechanisms, including chronic tissue inflammation and defective insulin signaling. We found that liver, muscle and adipose tissue exhibit higher levels of the chemotactic eicosanoid LTB4 in obese high-fat diet (HFD)-fed mice. Inhibition of the LTB4 receptor Ltb4r1, through either genetic or pharmacologic loss of function, led to an anti-inflammatory phenotype with protection from insulin resistance and hepatic steatosis. In vitro treatment with LTB4 directly enhanced macrophage chemotaxis, stimulated inflammatory pathways, reduced insulin-stimulated glucose uptake in L6 myocytes, and impaired insulin-mediated suppression of hepatic glucose output in primary mouse hepatocytes. This was accompanied by lower insulin-stimulated Akt phosphorylation and higher Irs-1/2 serine phosphorylation, and all of these events were dependent on Gαi and Jnk1, two downstream mediators of Ltb4r1 signaling. These observations elucidate a novel role of the LTB4-Ltb4r1 signaling pathway in hepatocyte and myocyte insulin resistance, and they show that in vivo inhibition of Ltb4r1 leads to robust insulin-sensitizing effects.

AB - Insulin resistance results from several pathophysiologic mechanisms, including chronic tissue inflammation and defective insulin signaling. We found that liver, muscle and adipose tissue exhibit higher levels of the chemotactic eicosanoid LTB4 in obese high-fat diet (HFD)-fed mice. Inhibition of the LTB4 receptor Ltb4r1, through either genetic or pharmacologic loss of function, led to an anti-inflammatory phenotype with protection from insulin resistance and hepatic steatosis. In vitro treatment with LTB4 directly enhanced macrophage chemotaxis, stimulated inflammatory pathways, reduced insulin-stimulated glucose uptake in L6 myocytes, and impaired insulin-mediated suppression of hepatic glucose output in primary mouse hepatocytes. This was accompanied by lower insulin-stimulated Akt phosphorylation and higher Irs-1/2 serine phosphorylation, and all of these events were dependent on Gαi and Jnk1, two downstream mediators of Ltb4r1 signaling. These observations elucidate a novel role of the LTB4-Ltb4r1 signaling pathway in hepatocyte and myocyte insulin resistance, and they show that in vivo inhibition of Ltb4r1 leads to robust insulin-sensitizing effects.

UR - http://www.scopus.com/inward/record.url?scp=84925485114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925485114&partnerID=8YFLogxK

U2 - 10.1038/nm.3800

DO - 10.1038/nm.3800

M3 - Article

C2 - 25706874

AN - SCOPUS:84925485114

VL - 21

SP - 239

EP - 247

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 3

ER -